UK markets close in 2 hours 39 minutes

Nicox S.A. (0RCQ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
3.3243+0.0043 (+0.13%)
As of 4:59PM BST. Market open.
Full screen
Previous close3.3200
Open3.3243
Bid0.0000 x 0
Ask0.0000 x 0
Day's range3.3243 - 3.3243
52-week range3.3243 - 3.3243
Volume216
Avg. volumeN/A
Market cap96.255M
Beta (5Y monthly)1.70
PE ratio (TTM)N/A
EPS (TTM)-0.5370
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Nicox Provides Third Quarter 2021 Business and Financial Highlights

    Press ReleaseNicox Provides Third Quarter 2021 Business and Financial Highlights VYZULTA® and ZERVIATE® prescriptions in the U.S. increased by 35% and 213% respectively in Q3 2021 compared to Q3 2020 Net Revenue of €2.4 million in the third quarter of 2021 and cash of €32.7 million on September 30, 2021 October 19, 2021– release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, provided business and financial highlights f

  • Globe Newswire

    Nicox to present at the OIS Glaucoma Virtual Innovation Showcase

    FOR INFORMATIONNicox to present at the OIS Glaucoma Virtual Innovation ShowcaseOctober 13, 2021 Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, announced that Mr Michele GARUFI, Chairman and Chief Executive Officer of Nicox, will present at the Ophthalmology Innovation Summit (OIS) Glaucoma Innovation Showcase being held virtually on October 21, 2021. Nicox’s presentation will be focused on nitric oxide in glaucoma. The video webcast

  • Globe Newswire

    Nicox Launches New Corporate & Investor Website

    Press ReleaseNicox Launches New Corporate & Investor WebsiteOctober 4, 2021 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced the launch of its redesigned corporate and investor website.The new corporate website, www.nicox.com, features: New visual image for NicoxIntroductory video on the CompanyMechanism-of-action video on NCX 470, our lead product candidate in glaucomaNew layout and easier acce